Vaccine For Herpes

There is currently no cure that can eradicate herpes virus from the body, but antiviral medications can reduce the frequency, duration, and severity of outbreaks. Very recent advances in the scientific understanding of medicinal plants suggest a much broader use in the treatment for herpes infections than science thought possible just ten years ago.
 Docosanol is available as a cream for direct application to the affected area of skin. It prevents HSV from fusing to cell membranes, thus barring the entry of the virus into the skin. Docosanol was approved for use after clinical trials by the FDA in July 2000. Docosanol is marketed by Avanir Pharmaceuticals under the name Abreva.
 Tromantadine is available as a gel that inhibits the entry and spread of the virus by altering the surface composition of skin cells and inhibiting release of viral genetic material. Zilactin is a topical analgesic barrier treatment, which forms a "shield" at the area of application to prevent a sore from increasing in size, and decrease viral spreading during the healing process.
 There is some limited research that has shown that tea tree oil may have topical anti-viral activity, especially with the herpes virus. Upon first feeling tingling or soreness in the area, prior to any physical manifestation, apply tea tree oil constantly for several hours. If caught early enough a cold sore will not form.
 Cimetidine, a common component of heartburn medication and probenecid has been shown to reduce the renal clearance of aciclovir. These compounds also reduce the rate, but not the extent, at which valaciclovir is converted into aciclovir. Another treatment is the use of petroleum jelly. Healing of cold sores is sped by barring water or saliva from reaching the sore.
 Limited evidence suggests that low dose aspirin might be beneficial in patients with recurrent HSV infections. Aspirin is a non-steroidal anti-inflammatory drug which reduces the level of prostaglandins that are essential in creating inflammation. A recent study in animals showed inhibition of thermal stress induced viral shedding of HSV-1 in the eye by aspirin, and a possible benefit in reducing the frequency of recurrences.
 The National Institutes of Health in the United States is currently conducting phase III trials of Herpevac, a vaccine against HSV-2. The vaccine has only been shown to be effective for women who have never been exposed to HSV-1. Overall, the vaccine is approximately 48% effective in preventing HSV-2 seropositivity and about 78% effective in preventing symptomatic HSV-2.
 During initial trials, the vaccine did not exhibit any evidence of preventing HSV-2 in males. Additionally, the vaccine only reduced the acquisition of HSV-2 and symptoms due to newly acquired HSV-2 among women who did not have HSV-2 infection at the time they got the vaccine. Because about 20% of persons in the United States have HSV-2 infection, this further reduces the population for whom this vaccine might be appropriate.
 Researchers at the University of Florida have made a hammerhead ribozyme that targets and cleaves the mRNA of essential genes in HSV-1. The hammerhead which targets the mRNA of the UL20 gene greatly reduced the level of HSV-1 ocular infection in rabbits and reduced the viral yield in vivo.
 The medical community has not had success to develop a treatment to successfully eradicate existing infections without causing extensive skin damage, trauma, or relapse. Importantly, China has now banned such vaccinations as they have found injecting a pathogen into your system does just that, it stays in your system, remaining latent in the joints, only to reappear in later years causing horrendous arthritis and or auto immune disorders.
 Recent reports quantify the very powerful antiviral activity of the plant extracts in OutbreakBalm-Rx in experimental and clinical medicine, especially as a herpes treatment against HSV-1 and 2. The plant extracts in this treatment for herpes contain naturally occurring phytoprotective chemicals, which are responsible for their antiviral activity and medicinal uses as genital herpes treatment or herpes simplex treatment.
 Our herpes treatments are characterized by strong pharmacological properties that confer them the character of "ethical drugs". The antiviral properties of the medicinal extracts in our herpes treatment formulae are undisputed. It is imperative that there is trust in the manufacturers who are the purveyors for quality, especially in the sensitive cases of herpes simplex treatment and genital herpes treatment.
 We have investigated hundreds of anti-HSV substances from natural sources. The main pharmacological effects of our anti-herpes treatments are their immunostimulative and antiviral functions. They are devoid of toxicity and negative side effects when used per instructions. To learn more, please go to http://www.forcesofnatureusa.com.

 http://7tipstreatmentforgout.blogspot.com/2013/02/treatment-for-gout.html